News Coverage

The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.

FDA Alert Regarding Counterfeit Alli

January 26, 2010

The U.S. FDA released an updated public health alert regarding counterfeit Alli being sold over the internet. According to the FDA, here’s what you need to know: Alli is an FDA-approved, over-the-counter weight loss drug. FDA lab tests have confirmed that counterfeit versions of the drug do not contain the FDA-approved active ingredient; rather, they…

Who is PharmacyChecker? Checking the Facts on PharmacyChecker.com

December 15, 2009

Who is PharmacyChecker.com? PharmacyChecker is a company that provided online pharmacy certification services for the major search engines until 2010. Why did the search engines stop using PharmacyChecker’s services? None of the search engines gave a public reason for ending their relationship with PharmacyChecker.  Several experts in the field, including our own Bryan Liang, criticized…

Partnerka, Counterfeit Drugs and the New Counterfeit Spam

November 25, 2009

The Partnership for Safe Medicines (PSM) has long reported on the growing issue of pharmaceutical spam advertising—and now SophosLab Canada has taken a closer look at the solicitation of counterfeit products online.

Spotlight on KnujOn: Combating Counterfeits Online – Conclusion

November 23, 2009

This is concludes our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company, on the subjects of counterfeit drugs sold online, search engine advertising what’s needed from regulators to protect Web users. PSM: FDA is preparing to receive public remarks regarding the online promotion of medical products and adverse event reporting. What recommendations…

Consumer Protection Group Applauds International Efforts to Combat Illegal Online Pharmacies

November 20, 2009

The Partnership for Safe Medicines (PSM) issued the following statement regarding the International Internet Week of Action, code named Operation Pangea II, intended to curb illegal actions involving medical products. PSM is a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines.

Spotlight on KnujOn: Combating Counterfeits Online, Part 4

November 18, 2009

This is part four of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 | Part 3 PSM:…

Spotlight on KnujOn: Combating Counterfeits Online, Part 3

November 17, 2009

This is part three of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 PSM: What steps have…

Spotlight on KnujOn: Combating Counterfeits Online, Part 2

November 16, 2009

This is part two of an interview with Garth Bruen, the co-founder of KnujOn, an internet compliance company, on the KnujOn system, search engine advertising and what’s needed from regulatory agencies to protect consumers from counterfeit medical products advertised online. Read part one of our interview. PSM: Have you noticed an uptick in the number…

Spotlight on KnujOn: Combating Counterfeits Online, Part 1

November 13, 2009

The dangers of online pharmacies and unlicensed drug sellers are well documented. In fact, recent reports released by KnujOn, an internet compliance company, found that 80 to 90 percent of search engine-sponsored advertisements of online drug pharmacies violate federal and state laws, including selling substandard and counterfeit drugs to unsuspecting consumers. To make matters worse,…

“Safe” Country Focus: United Kingdom

November 13, 2009

As my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.